Literature DB >> 20678748

Clinical features and the risk factors of infantile exotropia recurrence.

Ji-Hye Park1, Seung-Hyun Kim.   

Abstract

PURPOSE: To evaluate the clinical features and the risk factors of recurrence in infantile exotropia.
DESIGN: Retrospective, observational case series.
METHODS: The clinical records of 20 infantile exotropia patients who underwent exotropia surgery were reviewed retrospectively. Patients were divided into 2 groups according to the amount of exodeviation present at 1 year after surgery. Preoperative patient characteristics and postoperative alignments were evaluated at 1 day and 1, 3, 6, and 12 months after surgery.
RESULTS: The successful group was composed of 12 patients with an alignment of less than 10 prism diopters (PD) of exodeviation, and the recurrent group was composed of 8 patients with an alignment of 10 PD or more of exodeviation (range, 10 to 18 PD) at 1 year after surgery. The incidences of dissociated vertical deviation, inferior oblique overaction, and rates of constancy before operation were not significantly different in the 2 groups (P = .603, P = .158, and P = .347, respectively), and postoperative deviations were not significantly different at 1 day after surgery. However, postoperative deviations were significantly different in the 2 groups at 1 month (P = .069) and 3 months (P < .001) after surgery, and this difference was maintained at 12 months after surgery. Furthermore, correlation between initial alignments at 1 month after surgery and final alignments was significant in successful group (P = .012).
CONCLUSIONS: No single factor affecting the surgical outcome was identified in infantile exotropia, but the recurrence of infantile exotropia was apparent from the first postoperative month.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20678748     DOI: 10.1016/j.ajo.2010.05.004

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

Review 1.  Surgical treatment for residual or recurrent strabismus.

Authors:  Tao Wang; Li-Hua Wang
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

2.  The tendon width of lateral rectus muscle in predicting the effect of recession: is it just age-related artifact?

Authors:  C-M Yun; S-H Kim
Journal:  Eye (Lond)       Date:  2011-07-29       Impact factor: 3.775

3.  Augmented lateral rectus muscle recession for treatment of infantile exotropia.

Authors:  Lijuan Huang; Ningdong Li
Journal:  Int Ophthalmol       Date:  2022-01-29       Impact factor: 2.031

4.  Effects of Bilateral Medial Rectus Resection on Motor Outcomes in Infantile Exotropia.

Authors:  Teiji Yagasaki; Yoshimi Yokoyama; Ayaka Yagasaki; Makiko Tsukui
Journal:  Clin Ophthalmol       Date:  2022-06-21

5.  Prognostic factors predicting the surgical outcome of bilateral lateral rectus recession surgery for patients with infantile exotropia.

Authors:  Jason C S Yam; Gabriela S L Chong; Patrick K W Wu; Ursula S F Wong; Clement W N Chan; Simon T C Ko
Journal:  Jpn J Ophthalmol       Date:  2013-07-17       Impact factor: 2.447

6.  The Effect of Preoperative Occlusion Therapy on Long-term Outcome after Surgery for Early-onset Exotropia.

Authors:  Kwang Hoon Shin; Iris Naheah Kim; Hae Jung Paik
Journal:  Korean J Ophthalmol       Date:  2017-05-11

7.  Risk factors for excessive postoperative exo-drift after unilateral lateral rectus muscle recession and medial rectus muscle resection for intermittent exotropia.

Authors:  Shin Morisawa; Ichiro Hamasaki; Kiyo Shibata; Takehiro Shimizu; Reika Kono; Manabu Miyata; Takashi Furuse; Satoshi Hasebe; Hiroshi Ohtsuki; Yuki Morizane; Fumio Shiraga
Journal:  BMC Ophthalmol       Date:  2020-06-05       Impact factor: 2.209

8.  Comparison of Botulinum toxin type A with surgery for the treatment of intermittent exotropia in children.

Authors:  Han Su; Jing Fu; Xiao Wu; Ali Sun; Bowen Zhao; Jie Hong
Journal:  BMC Ophthalmol       Date:  2022-02-04       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.